- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: EXTRAORDINARY/SPECIAL GENERAL MEETING::VOLUNTARY | 3 | SGX Company Announcements | ||
| 04.09. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: CHANGE - ANNOUNCEMENT OF APPOINTMENT::APPOINTMENT OF GENERAL MANAGER | 1 | SGX Company Announcements | ||
| 04.09. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION OF THE COMPANY | 1 | SGX Company Announcements | ||
| TIANJIN PHARMACEUTICAL DA REN TANG Aktie jetzt für 0€ handeln | |||||
| 04.09. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::RESOLUTIONS PASSED AT THE 8TH BOARD MEETING FOR FY2026 | 1 | SGX Company Announcements | ||
| 31.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MONTHLY UPDATE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | - | SGX Company Announcements | ||
| 28.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MINUTES OF THE 1ST EXTRAORDINARY GENERAL MEETING OF THE COMPANY FOR FY2026 HELD ON 31 JULY 2026 | 1 | SGX Company Announcements | ||
| 26.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::ANNOUNCEMENT ON CONVENING AN ONLINE CONFERENCE | - | SGX Company Announcements | ||
| 14.08. | Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Profit Retreats In H1 | 2 | RTTNews | ||
| 14.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION OF THE COMPANY | 1 | SGX Company Announcements | ||
| 14.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::CONTINUOUS RISK ASSESSMENT REPORT OF TIANJIN PHARMACEUTICAL GROUP FINANCE CO., LTD. | 1 | SGX Company Announcements | ||
| 14.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::UPDATE ON THE DEPOSIT OF NET PROCEEDS AND THE USE OF NET PROCEEDS | 1 | SGX Company Announcements | ||
| 14.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::SECOND QUARTER AND/OR HALF YEARLY RESULTS | 2 | SGX Company Announcements | ||
| 14.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::RESOLUTIONS PASSED AT THE 7TH BOARD MEETING FOR FY2026 | 3 | SGX Company Announcements | ||
| 07.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::THE PROPOSED ENTRY INTO A WAREHOUSING AND LOGISTICS COOPERATION AS AN INTERESTED PERSON TRANSACTION | 2 | SGX Company Announcements | ||
| 07.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::THE PROPOSED ENTRY INTO AN ANNUAL DISTRIBUTION AGREEMENT AS AN INTERESTED PERSON TRANSACTION | 1 | SGX Company Announcements | ||
| 07.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::RESOLUTIONS PASSED AT THE 6TH BOARD MEETING FOR FY2026 | 2 | SGX Company Announcements | ||
| 07.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::ANNOUNCEMENT ON RECEIPT OF DRUG REGISTRATION CERTIFICATE BY XINXIN PHARMACEUTICAL PLANT | 3 | SGX Company Announcements | ||
| 04.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::UPDATE ON THE IMPLEMENTATION OF THE SHAREHOLDING INCREASE PLAN BY THE CONTROLLING SHAREHOLDER | 1 | SGX Company Announcements | ||
| 04.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::UPDATE ON THE IMPLEMENTATION OF THE SHAREHOLDING INCREASE PLAN BY THE CONTROLLING SHAREHOLDER | 2 | SGX Company Announcements | ||
| 31.07. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MONTHLY UPDATE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | 3 | SGX Company Announcements |
1 2 3 Weiter >>
58 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ASTRAZENECA | 137,45 | -0,51 % | Buy or Goodbye?: Meta, Apple, Rheinmetall und Astrazeneca - Die Analystenstimmen des Tages | © Foto: Julian Stratenschulte/dpa Meta, Apple, Rheinmetall und Astrazeneca: Die wichtigsten Analysten-Updates im Überblick Enthaltene Werte: US0378331005,DE0007030009,GB0009895292,US30303M1027Den vollständigen... ► Artikel lesen | |
| TEVA PHARMACEUTICAL INDUSTRIES | 31,500 | -1,56 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 11.09.2026 | Das Instrument NM1 GB00BMFCRZ80 SATSUMA TECH. LS -,001 EQUITY wird ex Kapitalmassnahme gehandelt am 11.09.2026 The instrument NM1 GB00BMFCRZ80 SATSUMA TECH. LS -,001 EQUITY is traded ex capital adjustment... ► Artikel lesen | |
| SINOPHARM | 1,708 | 0,00 % | Harbour BioMed and Sinopharm Enter Strategic Collaboration to Establish Innovation R&D Consortium | CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 27, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed... ► Artikel lesen | |
| CSPC PHARMA | 0,974 | +1,12 % | CSPC PHARMA Two Injection Products Approved for Clinical Trials in China | ||
| WUXI BIOLOGICS | 5,100 | -0,97 % | Transcenta Therapeutics and WuXi Biologics Enter into Strategic Collaboration to Accelerate Commercialization of HiCB Continuous Bioprocessing Technologies | PRINCETON, N.J. and SUZHOU, China, Sept. 9, 2026 /PRNewswire/ -- Transcenta Therapeutics (HKEX: 06628), a global clinical-stage biopharmaceutical company with fully... ► Artikel lesen | |
| OPKO HEALTH | 1,300 | +5,69 % | OPKO Health: Strategiewechsel hin zu Therapeutika, gestützt durch hohe Liquidität | ||
| SHANGHAI FOSUN PHARMACEUTICAL | 1,783 | -1,68 % | Shanghai Fosun Pharmaceutical (Group) Co., Ltd.: Fosun Pharma Announces H-Share Repurchase Plan of Up to HK$ 1 Billion | SHANGHAI, Sept 7, 2026 - (ACN Newswire) - Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ('Fosun Pharma', stock code: 600196.SH; 02196.HK) today announced an H share repurchase plan, under which the... ► Artikel lesen | |
| GEDEON RICHTER | 34,160 | 0,00 % | Gedeon Richter: Das "House of Hope" in Bamako leistet auch 2026 weiterhin lebenswichtige Hilfe für schutzbedürftige Frauen in Mali | BUDAPEST, UNGARN / ACCESS Newswire / 22. Juli 2026 / Das "Gedeon Richter House of Hope"-Zentrum in
Bamako, Mali, leistete auch in der ersten Hälfte des Jahres... ► Artikel lesen | |
| DR REDDYS | 10,200 | +0,99 % | DR REDDYS LABORATORIES LTD - 6-K, Report of foreign issuer | ||
| BAYER | 48,170 | -1,09 % | Nicht nur Bayer verdient am Weltmarkt mit, ohne überall selbst präsent zu sein: Ein australischer Psychedelika-Anbieter setzt auf dasselbe Grundprinzip | ||
| MERCK KGAA | 131,45 | -0,15 % | BARCLAYS stuft MERCK KGAA auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Merck KGaA von 140 auf 150 Euro angehoben, aber die Einstufung auf "Equal Weight" belassen. Analyst James Gordon... ► Artikel lesen | |
| YARROW BIOSCIENCE | 27,010 | 0,00 % | Yarrow Bioscience prices $150M public offering of common stock at $26 per share | ||
| BIODEXA PHARMACEUTICALS | 1,295 | -0,38 % | Biodexa Pharmaceuticals PLC: Interim results for the six months ended June 30, 2026 | September 11, 2026 Biodexa Pharmaceuticals PLC("Biodexa" or the "Company") Interim results for the six months ended June 30, 2026 Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical-stage biopharmaceutical... ► Artikel lesen | |
| NOVO NORDISK | 37,045 | -0,15 % | Novo Nordisk machte GLP-1 zum Milliardenmarkt, CAR-T die Krebsmedizin - welche Biotech-Plattform kommt als Nächstes? | ||
| AQUESTIVE THERAPEUTICS | 4,775 | -0,10 % | Aquestive Therapeutics, Inc.: Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update | Successfully completed human factors validation study and pharmacokinetic study for Anaphylm (dibutepinephrine) sublingual filmRemains on track to resubmit Anaphylm NDA to the FDA in Q3 2026Continues... ► Artikel lesen |
Das Unternehmen TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORP LTD kann der Branche Pharma zugeordnet werden. Der aktuelle Kurs liegt bei 2,100 Euro und damit 0,00 % im Plus. Die Dividendendrendite beträgt aktuell 0,00 % (berechnet anhand der Ausschüttung von 0,00 Euro in den letzten 12 Monaten).
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORP LTD finden Sie auf Wallstreet Online.